Sbir phase II, topic 019: electrospun biodegradable membrane inserts
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95021C00024
- Awardee
-
Innovative Surface Technologies Inc. UEI HA96NDV2J3L5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,972,191
Award facts
- Opportunity
-
- PHS20201PHASEIIRFP Solicitation number
- Contract value 100% obligated
- $1,972,191.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541713 Research and Development in Nanotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- St Paul, MN 55114, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,972,191 |
About this award
The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $1,972,191.00 firm fixed price contract to Innovative Surface Technologies Inc. (doing business as Isurtec) for research and development of electrospun biodegradable membrane inserts under the Small Business Innovation Research (SBIR) Program Phase II. The contract is designated as a total small business set-aside. Isurtec is a for-profit manufacturer of coatings and surface transformation technologies for the biotech and medical device industries. The contract supports the NIH's efforts to advance biomedical technologies. Isurtec was previously awarded a $225,000 SBIR Phase I contract in 2020 for developing alternatives to commercially available cell culture insert membranes and manufacturing techniques.
Quick answers
Who was awarded contract 75N95021C00024?
75N95021C00024 was awarded to Innovative Surface Technologies Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2021.
How much is contract 75N95021C00024 worth?
The government has obligated $1,972,191 on 75N95021C00024.
Which agency awarded contract 75N95021C00024?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021C00024, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021C00024 competed?
The extent of competition for 75N95021C00024 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award